rts logo

Positives for Sunshine Biopharma Inc (SBFM) as stock gains in recent trading

Sunshine Biopharma Inc (NASDAQ: SBFM) is -69.83% lower on its value in year-to-date trading and has touched a low of $0.04 and a high of $1.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SBFM stock was last observed hovering at around $0.11 in the last trading session, with the day’s loss setting it -0.03%.

Currently trading at $0.08, the stock is 35.71% and -31.87% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 26.71 million and changing -23.10% at the moment leaves the stock -73.27% off its SMA200. SBFM registered -88.75% loss for a year compared to 6-month loss of -74.41%. The firm has a 50-day simple moving average (SMA 50) of -$0.49 and a 200-day simple moving average (SMA200) of $0.38.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 47.83% gain in the last 1 month and extending the period to 3 months gives it a -69.83%, and is 42.19% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.70% over the week and 19.52% over the month.

Sunshine Biopharma Inc (SBFM) has around 44 employees, a market worth around $8.14M and $24.09M in sales. Profit margin for the company is -18.70%. Distance from 52-week low is 86.56% and -94.15% from its 52-week high. The company has generated returns on investments over the last 12 months (-20.72%).

Sunshine Biopharma Inc quarterly earnings per share for the current quarter are estimated at -$0.08 with sales reaching $7M over the same period., but quarterly earnings will post 84.30% year-over-year.

Sunshine Biopharma Inc (SBFM) Top Institutional Holders

17 institutions hold shares in Sunshine Biopharma Inc (SBFM), with institutional investors hold 7.19% of the company’s shares. The shares outstanding are 99.45M, and float is at 91.94M with Short Float at 1.06%. Institutions hold 6.51% of the Float.

The top institutional shareholder in the company is Armistice Capital, LLC with over 2.19 million shares valued at $1.08 million. The investor’s holdings represent 0.42% of the SBFM Shares outstanding. As of Jun 29, 2023, the second largest holder is Bridgeway Capital Management, Inc. with 0.29 million shares valued at $0.14 million to account for 0.06% of the shares outstanding.

Sunshine Biopharma Inc (SBFM) Insider Activity

The most recent transaction is an insider purchase by Slilaty Steve N.,the company’sChief Executive Officer. SEC filings show that Slilaty Steve N. bought 100,000 shares of the company’s common stock on Mar 04 ’24 at a price of $0.10 per share for a total of $10000.0. Following the purchase, the insider now owns 0.13 million shares.

Sunshine Biopharma Inc disclosed in a document filed with the SEC on Feb 08 ’24 that Slilaty Steve N. (Chief Executive Officer) bought a total of 20,000 shares of the company’s common stock. The trade occurred on Feb 08 ’24 and was made at $0.10 per share for $2000.0. Following the transaction, the insider now directly holds 30000.0 shares of the SBFM stock.

Related Posts